Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Rizzo

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|April 28, 2015
Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantationR F Cornell, X Zhong, C Arce-Lara, et al.
Bone Marrow Transplantation|July 3, 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancerJ D Rizzo, S Williams, J T Wu, et al.
Bone Marrow Transplantation|December 11, 2012
Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantationN S Majhail, J D Rizzo, T Hahn, et al.
Bone Marrow Transplantation|April 19, 2016
Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot studyE M Denzen, V Thao, T Hahn, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
Bone Marrow Transplantation|March 8, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Hematology/Oncology and Stem Cell Therapy|March 27, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Journal of Medicinal Chemistry|March 15, 1996
Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomersM T Flavin, J D Rizzo, A Khilevich, et al.
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Bone Marrow Transplantation|April 20, 2010
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasiaJ P Uberti, M-A Agovi, S Tarima, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|April 28, 2015
Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantationR F Cornell, X Zhong, C Arce-Lara, et al.
Bone Marrow Transplantation|July 3, 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancerJ D Rizzo, S Williams, J T Wu, et al.
Bone Marrow Transplantation|December 11, 2012
Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantationN S Majhail, J D Rizzo, T Hahn, et al.
Bone Marrow Transplantation|April 19, 2016
Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot studyE M Denzen, V Thao, T Hahn, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
Bone Marrow Transplantation|March 8, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Hematology/Oncology and Stem Cell Therapy|March 27, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Journal of Medicinal Chemistry|March 15, 1996
Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomersM T Flavin, J D Rizzo, A Khilevich, et al.
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Bone Marrow Transplantation|April 20, 2010
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasiaJ P Uberti, M-A Agovi, S Tarima, et al.
Pageof 4